Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Non-cash Items (2023 - 2025)

Beta Bionics' Non-cash Items history spans 3 years, with the latest figure at $141.9 million for Q4 2025.

  • For Q4 2025, Non-cash Items rose 518.98% year-over-year to $141.9 million; the TTM value through Dec 2025 reached $141.9 million, up 518.98%, while the annual FY2025 figure was $141.9 million, 518.98% up from the prior year.
  • Non-cash Items for Q4 2025 was $141.9 million at Beta Bionics, up from $3.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $141.9 million in Q4 2025 and bottomed at $535000.0 in Q4 2023.
  • The 3-year median for Non-cash Items is $13.3 million (2024), against an average of $36.5 million.
  • The largest annual shift saw Non-cash Items skyrocketed 4185.79% in 2024 before it skyrocketed 518.98% in 2025.
  • A 3-year view of Non-cash Items shows it stood at $535000.0 in 2023, then surged by 4185.79% to $22.9 million in 2024, then surged by 518.98% to $141.9 million in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Non-cash Items are $141.9 million (Q4 2025), $3.5 million (Q3 2025), and $3.6 million (Q2 2025).